Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04167189 · ClinicalTrials.gov registry record · Early Phase 1
Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD
A Early Phase 1 study, sponsored by PhenoSolve.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT04167189 is a Early Phase 1 study that has completed, run by PhenoSolve. The registered enrollment target is 28 participants.
The verdict
NCT04167189, a Early Phase 1 study, has completed, sponsored by PhenoSolve.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This work will assess the prevalence in hard-to-treat ADHD of the ineffectiveness of the anesthetic Lidocaine.
Interventions
- DRUG Lidocaine gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-01-20 |
| Est. Completion | 2020-03-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04167189
The ClinicalTrials.gov registry entry for NCT04167189 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhenoSolve, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine gel is the first listed.
NCT04167189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04167189 about?
NCT04167189 is a clinical study titled "Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD". This work will assess the prevalence in hard-to-treat ADHD of the ineffectiveness of the anesthetic Lidocaine.
What is the current status of trial NCT04167189?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2018-01-20. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT04167189?
The interventions under investigation include: Lidocaine gel (DRUG).
Who is sponsoring clinical trial NCT04167189?
This trial is sponsored by PhenoSolve, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.